How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

According to Rogers, the computer science faculty use Gradescope’s Measure Of Software Similarity (MOSS) tool to identify ...

举个例子，GPT-3 第一个版本 175B（约 1750 ...

这项研究由来自美国伊利诺伊大学厄巴纳-香槟分校、斯坦福大学、英伟达和麻省理工学院的研究团队联合完成，以预印本形式于2026年4月28日发布在arXiv平台，论文编号为arXiv:2604.25917v1。研究背景：一个AI打天下，为什么越来越吃力？先 ...